Cooley Helps Atomwise Nab $123M For Drug Discovery Tech
Atomwise Inc. said Tuesday it raised $123 million in a funding round co-led by B Capital Group and Sanabil Investments that the Cooley LLP-guided drug discovery company will use to expand...To view the full article, register now.
Already a subscriber? Click here to view full article